ADIL
ADIAL PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$4.86
−6.72%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- -$0.17
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$11
- EPS estimate
- -$1.03
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -252.8%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$1.03 | -$11 | Miss -992.23% | — |
| May 8, 2026 | -$2.73 | -$1.48 | Beat 45.79% | — |
| Mar 10, 2026 | -$2.13 | -$3.75 | Miss -76.06% | — |
| Nov 13, 2025 | -$2.25 | -$2.00 | Beat 11.11% | — |
| Aug 13, 2025 | -$0.22 | -$0.18 | Beat 18.18% | — |
| May 14, 2025 | -$0.50 | -$0.34 | Beat 32.00% | — |
| Mar 4, 2025 | -$0.38 | -$0.15 | Beat 60.53% | — |
| Apr 4, 2024 | -$0.76 | -$1.35 | Miss -77.63% | — |
| Nov 14, 2023 | -$1.14 | -$1.14 | In line | — |
| Aug 21, 2023 | -$1.50 | -$1.33 | Beat 11.33% | — |
| May 12, 2023 | -$3.50 | -$2.75 | Beat 21.43% | — |
| Nov 14, 2022 | -$4.50 | -$3.00 | Beat 33.33% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026